Cytodyn Inc (CYDY)

[Saltz]

I'll state the obvious. Very positive recent FDA news and what appears to be very disruptive technology in Pro-140. One would conclude enrollment would be a slam dunk. The question, as everyone knows on today's CC is why haven't we enrolled 30 patients and how long is it going to take???? A little nerve racking when we are looking at 300 patients in the Mono PIII. I hope we get some answers that make sense and a clear plan that gets things moving. The SP reflects lack of confidence in managements ability to execute. IMO there had to be issues with the protocol that made enrollment a lengthy process with the Adjunct PIII. The FDA said ok then we will reduce to 30 patients but the protocol remains unchanged. I have a feeling the Mono PIII will be much easier to enroll. Shareholders need assurance that management can execute. For the last year it has been a long list of delays and that needs to change.